Results 381 to 390 of about 3,932,956 (396)

Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

Nature Medicine, 2018
Jacqulyne Robichaux, Yasir Y Elamin, Zhi Tan   +2 more
exaly  

Protease Inhibitors

Materials and Methods, 2013
openaire   +1 more source

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Cancer Cell, 2011
Wei Xu, Hui Yang, Ping Wang
exaly  

Protease inhibitors

Reactions Weekly, 2002
openaire   +1 more source

C1 inhibitor, a multi-functional serine protease inhibitor

Thrombosis and Haemostasis, 2010
A. Davis, Fengxin Lu, Pedro Mejia
semanticscholar   +1 more source

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2018
Christina Lacchetti, Michael B Atkins, Ian Chau   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Protease Inhibitors

2011
openaire   +1 more source

Protease Inhibitors

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
openaire   +1 more source

Protease inhibitors

2006
openaire   +1 more source